Cubist Hits Hospira With Patent Suit Over Generic Cubicin

Law360, New York (July 10, 2012, 2:41 PM EDT) -- Cubist Pharmaceuticals Inc. lodged a suit against Hospira Inc. in Delaware federal court on Monday, claiming the generic-drug maker infringed a patent covering its drug Cubicin, an IV antibiotic used to treat skin and blood infections.

Lexington, Mass.-based Cubist filed the suit after Hospira allegedly sought U.S. Food and Drug Administration approval to make and market a generic version of Cubicin in violation of Cubist’s patent rights.

“Hospira’s submission of [abbreviated new drug application] No. 202587 for the purpose of obtaining approval to engage in the...
To view the full article, register now.